2026-526224-48-02招募中4 期
Bioequivalence study of Vitamin D3 Pharma Patent 20,000 IU and the Vigantol 20,000 IU oral drops solutions and assessment of bioavailability in healthy volunteers
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Contact Point
Scientific
Pharma Patent Kft.
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
4 期
Comparative Evaluation of Three Vitamin D3 Formulations for Sequential Improvement of Vitamin D3 Levels throughout a period of 3-Months.CTRI/2024/02/063141Dr Roshan Pawar90
招募中
4 期
Efficacy comparison of two doses of vitamin D3 in critically ill patients undergoing continuous renal replacement therapy - NephroD2024-510834-42-00Uniwersytecki Szpital Kliniczny W Opolu138
已完成
不适用
Bioequivalence study for vitamin D3 pharmacokinetic parameters following single oral administrations of vitamin D3 1000 IU with cyclodextrin and vitamin D3 1000 IU without cyclodextrin in Caucasian healthy volunteersporous bones10005959OsteoporosisNL-OMON37168Institut de Recherches Internationales Servier I.R.I.S54
撤回
3 期
A PHASE III OPEN LABEL STUDY CONTROLLED BY VITAMIN D3 SUPPLEMENTATION AND THE DIFFERENCES BETWEEN YOUNG ADULTS AND SENIOR POPULATION2024-511889-36-01Fakultni Nemocnice Plzen150
尚未招募
2 期
A study to show the effect Of Vitamin D Supplementation On Serum Pigment epithelium deerived factor and vascular endothelial growth factor in Diabetic Retinopathy patientsCTRI/2025/02/080622Institute of Ophthalmology JNMC, AMU120